Pharma And Health Reform: Staying On The Sidelines Works Out

The failure of the GOP effort to repeal the Affordable Care Act came after a lot of health care stakeholders warned that proposals in the Senate would lead to a disaster. The pharmaceutical industry maintained its silence on the bill – and probably ends up as one of the winners as the dust settles.

Capitol House

After Sen. John McCain (R-Ariz.) cast his dramatic thumbs down vote on the last ditch Senate effort to repeal the Affordable Care Act, the pharmaceutical industry’s decision to stay out of the public debate over the effort looked pretty smart.

By the time McCain voted in the early morning hours of July 28, most of the repeal and replace bill...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access